While human clinical trials remain limited, the preclinical evidence creates strong theoretical support for therapeutic applications
Oral B12 supplements are non-invasive and convenient but may have lower absorption rates
BPC 157 is just one example of the many peptides that have been studied for their therapeutic potential
The peptide reduces inflammatory cytokine expression in various injury models, contributing to resolution of inflammation and transition to regenerative healing phases
This was confirmed by knockout mouse studies where acute effects persisted but chronic weight loss was abolished without 3-AR
Mount Sinai, Vitamin B12 deficiency anemia, Niranjan N Singh, Florian P Thomas, Alan L Diamond at al, Vitamin B12-Associated Neurological Diseases, Medscape Mathew, A.R